| Property | Value |
|
has major subject area list
|
Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Imidazoles; Melanoma, Experimental; Toll-Like Receptor 7; Toll-Like Receptor 8; Xanthones
|
|
information resource reference
|
Seth A, Lee H, Cho MY, Park C, Korm S, Lee JY, Choi I, Lim YT, Hong KS. Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy. Oncotarget. 2017 Jan 17; 8(3):5371-5381. PMID: 28036266.
|
|
label
|
Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.
|